4.4 Article

Haploidentical γδ T Cells Induce Complete Remission in Chemorefractory B-cell Non-Hodgkin Lymphoma

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

Nikhil C. Munshi et al.

Summary: The phase 2 study confirmed the efficacy and safety of ide-cel in patients with relapsed and refractory myeloma, with a majority of patients achieving responses and 26% achieving MRD-negative status. Despite the high response rate, almost all patients experienced grade 3 or 4 toxic effects, including hematologic toxic effects and cytokine release syndrome.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Review Immunology

γδ T cells in cancer

Bruno Silva-Santos et al.

NATURE REVIEWS IMMUNOLOGY (2015)

Article Medicine, Research & Experimental

Successful adoptive transfer and in vivo expansion of haploidentical γδ T cells

Martin Wilhelm et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2014)

Review Immunology

Antigen recognition by human γδ T cells:: pattern recognition by the adaptive immune system

CT Morita et al.

SPRINGER SEMINARS IN IMMUNOPATHOLOGY (2000)